TD Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.03M Buy
240,358
+4,637
+2% +$77.7K ﹤0.01% 796
2025
Q1
$3.62M Sell
235,721
-198,833
-46% -$3.06M ﹤0.01% 830
2024
Q4
$9.58M Buy
434,554
+210,860
+94% +$4.65M 0.01% 654
2024
Q3
$3.91M Sell
223,694
-1,415
-0.6% -$24.7K ﹤0.01% 851
2024
Q2
$3.66M Buy
225,109
+2,621
+1% +$42.6K ﹤0.01% 835
2024
Q1
$3.14M Sell
222,488
-5,000
-2% -$70.6K ﹤0.01% 891
2023
Q4
$2.37M Buy
227,488
+3,053
+1% +$31.9K ﹤0.01% 954
2023
Q3
$2.29M Sell
224,435
-1,200
-0.5% -$12.2K ﹤0.01% 923
2023
Q2
$1.7M Sell
225,635
-1,145
-0.5% -$8.62K ﹤0.01% 1004
2023
Q1
$2.01M Sell
226,780
-3,486
-2% -$30.9K ﹤0.01% 985
2022
Q4
$2.1M Sell
230,266
-4,400
-2% -$40.1K ﹤0.01% 974
2022
Q3
$1.84M Sell
234,666
-7,591
-3% -$59.4K ﹤0.01% 1027
2022
Q2
$1.82M Sell
242,257
-6,300
-3% -$47.4K ﹤0.01% 1035
2022
Q1
$2.33M Buy
248,557
+6,500
+3% +$61K ﹤0.01% 1041
2021
Q4
$1.94M Sell
242,057
-6,900
-3% -$55.3K ﹤0.01% 1141
2021
Q3
$2.43M Sell
248,957
-3,400
-1% -$33.1K ﹤0.01% 1034
2021
Q2
$2.44M Buy
252,357
+4,200
+2% +$40.5K ﹤0.01% 1033
2021
Q1
$2.86M Buy
248,157
+2,100
+0.9% +$24.2K ﹤0.01% 997
2020
Q4
$2.37M Buy
246,057
+1,720
+0.7% +$16.6K ﹤0.01% 989
2020
Q3
$2.2M Buy
244,337
+7,057
+3% +$63.6K ﹤0.01% 882
2020
Q2
$2.93M Sell
237,280
-4,200
-2% -$51.8K ﹤0.01% 788
2020
Q1
$2.17M Sell
241,480
-3,000
-1% -$26.9K ﹤0.01% 818
2019
Q4
$2.4M Sell
244,480
-65,900
-21% -$646K ﹤0.01% 888
2019
Q3
$2.14M Sell
310,380
-5,600
-2% -$38.5K ﹤0.01% 898
2019
Q2
$2.92M Buy
315,980
+24,100
+8% +$222K ﹤0.01% 826
2019
Q1
$4.58M Buy
291,880
+11,300
+4% +$177K 0.01% 716
2018
Q4
$4.33M Buy
280,580
+4,600
+2% +$70.9K 0.01% 705
2018
Q3
$5.95M Buy
275,980
+5,700
+2% +$123K 0.01% 672
2018
Q2
$6.57M Buy
270,280
+25,200
+10% +$613K 0.01% 628
2018
Q1
$4.19M Buy
245,080
+1,400
+0.6% +$23.9K 0.01% 719
2017
Q4
$4.62M Sell
243,680
-74,600
-23% -$1.41M 0.01% 687
2017
Q3
$5.6M Sell
318,280
-1,882,304
-86% -$33.1M 0.01% 637
2017
Q2
$73.1M Buy
2,200,584
+96,857
+5% +$3.22M 0.12% 144
2017
Q1
$67.5M Sell
2,103,727
-64,519
-3% -$2.07M 0.11% 155
2016
Q4
$78.6M Buy
2,168,246
+241,049
+13% +$8.74M 0.13% 131
2016
Q3
$88.7M Buy
1,927,197
+26,132
+1% +$1.2M 0.15% 125
2016
Q2
$95.5M Buy
1,901,065
+333,797
+21% +$16.8M 0.17% 115
2016
Q1
$83.9M Sell
1,567,268
-221,416
-12% -$11.8M 0.16% 115
2015
Q4
$117M Buy
1,788,684
+615,081
+52% +$40.4M 0.23% 88
2015
Q3
$66.3M Buy
1,173,603
+950,651
+426% +$53.7M 0.13% 135
2015
Q2
$13.2M Sell
222,952
-208,124
-48% -$12.3M 0.02% 443
2015
Q1
$26.9M Buy
431,076
+171,990
+66% +$10.7M 0.05% 279
2014
Q4
$14.9M Buy
259,086
+8,474
+3% +$487K 0.02% 398
2014
Q3
$13.5M Sell
250,612
-4,745
-2% -$255K 0.02% 407
2014
Q2
$13.4M Buy
255,357
+93,257
+58% +$4.89M 0.02% 412
2014
Q1
$8.57M Sell
162,100
-47,825
-23% -$2.53M 0.02% 498
2013
Q4
$8.41M Sell
209,925
-223,443
-52% -$8.96M 0.02% 492
2013
Q3
$16.4M Buy
433,368
+53,258
+14% +$2.01M 0.03% 330
2013
Q2
$14.9M Buy
+380,110
New +$14.9M 0.03% 328